Conditions: Type 2 Diabetes Mellitus
Keywords: Phase 1 type 2 diabetes monotherapy PF-04937319
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 12
Healthy volunteers: no

Brief summary:
Study B1621018 will assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Dose Levels of Pf-04937319 in Japanese Subjects with Type 2 Diabetes Mellitus As Monotherapy

Detailed description:

Arms:
arm 1: PF-04937319 Split dose arm 2: Placebo split dose

Interventions: intervention 1: PF-04937319 high dose intervention 2: PF-04937319 low dose intervention 3: Placebo
Intervention descriptions: intervention 1: tablets, 150 mg with breakfast plus 100 mg with lunch, 7 days intervention 2: tablets, 50 mg with breakfast plus 50 mg with lunch, 7 days intervention 3: tablets, breakfast plus lunch, 7 days

Protocol document: